Guideline / position statementindependent cross-checkfull text checked I-GUT-109 standard review
Warning signs that need a doctor
Suspected cancer: recognition and referral (NICE guideline NG12), section 1.2 upper gastrointestinal tract cancers
Overview
National Institute for Health and Care Excellence (NICE). NICE guideline NG12 2015 (last updated 15 April 2026)
Difficulty swallowing, vomiting blood, or weight loss with reflux at 55 or older should be checked for cancer.
Does the study support the specific claim? No · Methodological quality: high
Plain-language summary
Study explained simply
- What did the researchers want to find out?
Define when to suspect upper GI cancer.
- How was the study done?
National guideline.
- How many people, animals or samples were studied?
Adults in primary care.
- What was actually found?
Dysphagia, weight loss, haematemesis and anaemia trigger referral or endoscopy.
- How large was the observed effect?
Not applicable.
- What do the results mean in everyday life?
Such symptoms must be checked, not treated by diet alone.
- What are the study's limitations?
UK thresholds.
- What does it say about Elawady's specific claim?
Supports the safety warning.
- Do the results apply to Germany and Europe?
Applies to Europe.
- What can explicitly not be concluded from this study?
Not about diet efficacy.
Scientific in-depth review
1. Full reference
- Authors
- National Institute for Health and Care Excellence (NICE)
- Journal
- NICE guideline NG12
- Year
- 2015 (last updated 15 April 2026)
- Identifier
- Verification
- verified – Fetched URL 2026-10-26 (HTTP 200, page text read)
- Retracted
- no
- Corrections
- none
- Extent checked
- full text
- Conflicts of interest and funding
NICE (public body)
2. Research question
Which symptoms should prompt referral for suspected oesophageal and stomach cancer?
3. Study design and population
- Study design
- Guideline / position statement – National clinical guideline (referral criteria)
- Population
Adults in primary care
- Country
UK (England)
- Period
2015, amended 2025, page updated April 2026
- Sample size
Not applicable
- Inclusion and exclusion criteria
Not applicable
4. Methods and endpoints
- Exposure / intervention
Symptoms
- Comparator
Not applicable
- Endpoints
Referral recommendations
- Statistical methods
Not applicable
5. Actual results
- Results
1.2.1/1.2.7: refer on a suspected cancer pathway people with dysphagia, or aged 55 and over with weight loss plus upper abdominal pain, reflux or dyspepsia. 1.2.2/1.2.8: consider endoscopy for haematemesis. 1.2.3/1.2.9: consider endoscopy at 55+ with treatment-resistant dyspepsia, upper abdominal pain with low haemoglobin, or raised platelets/nausea/vomiting with weight loss, reflux, dyspepsia or upper abdominal pain.
- Absolute risks
Not applicable
- Authors' conclusion
Alarm symptoms require investigation.
6. Strengths
- Official, current
7. Weaknesses
- UK-specific thresholds
8. Risk of bias
- Orienting tool
- none applicable
- Type of assessment
- simplified assessment (abstract only)
- Full formal assessment
- no
- Overall risk of bias
- not assessable
- Rationale
Guideline.
9. Assessment of the statistical interpretation
Not applicable
10. Relevance to the specific claim
Defines alarm symptoms that must not be managed by diet alone (safety note of C-GUT-02 and C-PPI-09/10).
11. Independent contrary findings
None.
12. Transferability to Germany and Europe
Applicable; age thresholds may differ in Egypt where gastric cancer epidemiology differs.
13. Overall methodological judgement
Supports the safety notes.
| Multidimensional assessment | |
|---|---|
| Authenticity of the source | verified |
| Methodological quality | high |
| Risk of bias | not assessable |
| Precision of results | not applicable |
| Directness | direct |
| Reproducibility | unknown |
| Consistency with the overall evidence | consistent |
| Regional transferability | high |
| Adequacy of the interpretation (by the archive) | not applicable |
14. Open questions
None.
15. Linked fact checks
- Stopping bread and baked goods for five days will improve 85% of reflux and IBS symptoms within at most ten days; both diseases can be eliminated completely. – Studies contradicting or limiting the claim
- All acid-suppressing medicines (PPIs and H2 blockers) are permanently forbidden; heartburn should stop through the diet, not through drugs. – Studies contradicting or limiting the claim